Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2002-7-31
pubmed:abstractText
Very-low-level methicillin-resistant Staphylococcus aureus (MRSA), or class 1 MRSA, is often misdiagnosed as methicillin-susceptible S. aureus (MSSA). We evaluated the performances of three methods for detection of low-level methicillin resistance: the disk diffusion method using the cephamycin antibiotics cefoxitin and moxalactam, the Vitek 2 system (bioMérieux), and the MRSA-screen test (Denka). Detection of the mecA gene by PCR was considered to be the "gold standard." We also determined the sensitivity of the oxacillin disk diffusion method with 5- and 1-microg disks and that of the Oxascreen agar assay with 6 mg of oxacillin liter(-1) for detection of MRSA. We compared the distributions of MICs of oxacillin and cefoxitin by the E-test (AB Biodisk), and those of moxalactam by dilutions in agar, for MRSA and MSSA isolates. The 152 clinical isolates of S. aureus studied were divided into 69 MSSA (mecA-negative) and 83 MRSA (mecA-positive) isolates, including 63 heterogeneous isolates and 26 class 1 isolates (low-level resistance). The cefoxitin and moxalactam disk diffusion tests detected 100% of all the MRSA classes: cefoxitin inhibition zone diameters were <27 mm, and moxalactam inhibition zone diameters were <24 mm. The Vitek 2 system and the MRSA-screen test detected 94 and 97.6% of all MRSA isolates, respectively. The sensitivities of the 5- and 1-microg oxacillin disks were 95.2 and 96.4%, respectively, whereas that of the Oxascreen agar screen assay was 94%. All of the tests except the 1-microg oxacillin disk test were 100% specific. For the class 1 MRSA isolates, the sensitivity of the Vitek 2 test was 92.3%, whereas those of the MRSA-screen test and the disk diffusion method with cefoxitin and moxalactam were 100%. Therefore, the cefoxitin and moxalactam disk diffusion methods were the best-performing tests for routine detection of all classes of MRSA.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-10203531, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-10325346, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-10449453, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-10501104, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-10585805, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-10589891, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-10610377, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-10618085, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-10834971, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-11073727, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-11136748, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-12843124, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-15365061, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-1810190, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-1995724, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-2014967, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-2599989, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-3499862, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-7494490, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-7665669, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-8152163, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-8870626, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-8878592, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-8994782, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-9336672, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-9431919, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-9486753, http://linkedlifedata.com/resource/pubmed/commentcorrection/12149327-9876208
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0095-1137
pubmed:author
pubmed:issnType
Print
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2766-71
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:12149327-Bacterial Proteins, pubmed-meshheading:12149327-Carrier Proteins, pubmed-meshheading:12149327-Cefoxitin, pubmed-meshheading:12149327-Gene Expression Regulation, Bacterial, pubmed-meshheading:12149327-Hexosyltransferases, pubmed-meshheading:12149327-Hospitalization, pubmed-meshheading:12149327-Humans, pubmed-meshheading:12149327-Lactams, pubmed-meshheading:12149327-Latex Fixation Tests, pubmed-meshheading:12149327-Methicillin, pubmed-meshheading:12149327-Methicillin Resistance, pubmed-meshheading:12149327-Microbial Sensitivity Tests, pubmed-meshheading:12149327-Moxalactam, pubmed-meshheading:12149327-Muramoylpentapeptide Carboxypeptidase, pubmed-meshheading:12149327-Oxacillin, pubmed-meshheading:12149327-Penicillin-Binding Proteins, pubmed-meshheading:12149327-Peptidyl Transferases, pubmed-meshheading:12149327-Staphylococcal Infections, pubmed-meshheading:12149327-Staphylococcus aureus
pubmed:year
2002
pubmed:articleTitle
Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test.
pubmed:affiliation
Service de Bactériologie-Virologie-Hygiène, Hôpital Saint-Louis, 75475 Paris Cedex 10, France. annie.felten@sls.ap-hop-paris.fr
pubmed:publicationType
Journal Article, Evaluation Studies